Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Inhibitor Therapeutics, Inc.Listing on record | Buy | $5.2K | conv 71Unusual size | SEC | |
Inhibitor Therapeutics, Inc.Listing on record | Buy | $3.3K | conv 67First in 12mo | SEC | |
Inhibitor Therapeutics, Inc.Listing on record | AwardD (derivative) | $13.7K | SEC | ||
Inhibitor Therapeutics, Inc.Listing on record | Buy | $2.3K | conv 67First in 12mo | SEC | |
Inhibitor Therapeutics, Inc.Listing on record | Buy | $1.6K | conv 54First in 12mo | SEC | |
Inhibitor Therapeutics, Inc.Listing on record | Award | $4.1K | Unusual size | SEC | |
Inhibitor Therapeutics, Inc.Listing on record | AwardD (derivative) | $29K | SEC | ||
Inhibitor Therapeutics, Inc.Listing on record | AwardD (derivative) | $29K | SEC | ||
Inhibitor Therapeutics, Inc.Listing on record | AwardD (derivative) | $29K | SEC | ||
Inhibitor Therapeutics, Inc.Listing on record | AwardD (derivative) | $18K | SEC |